<SEC-DOCUMENT>0001209191-22-059172-index.html : 20221201
<SEC-HEADER>0001209191-22-059172.hdr.sgml : 20221201
<ACCEPTANCE-DATETIME>20221201160154
ACCESSION NUMBER:		0001209191-22-059172
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20221129
FILED AS OF DATE:		20221201
DATE AS OF CHANGE:		20221201

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			ASELAGE STEVE
		CENTRAL INDEX KEY:			0001221599

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33004
		FILM NUMBER:		221438821

	MAIL ADDRESS:	
		STREET 1:		6300 DUMBARTON CIRCLE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94555

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acer Therapeutics Inc.
		CENTRAL INDEX KEY:			0001069308
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				320426967
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		ONE GATEWAY CENTER (300 WASHINGTON ST.)
		STREET 2:		SUITE 356
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02458
		BUSINESS PHONE:		(844) 902-6100

	MAIL ADDRESS:	
		STREET 1:		ONE GATEWAY CENTER (300 WASHINGTON ST.)
		STREET 2:		SUITE 356
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02458

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Opexa Therapeutics, Inc.
		DATE OF NAME CHANGE:	20060616

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PharmaFrontiers Corp.
		DATE OF NAME CHANGE:	20051011

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHARMAFRONTIERS CORP
		DATE OF NAME CHANGE:	20040816
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>